Literature DB >> 33692800

Immune Responses to Pseudomonas aeruginosa Biofilm Infections.

Claus Moser1, Peter Østrup Jensen1,2, Kim Thomsen1, Mette Kolpen1, Morten Rybtke2, Anne Sofie Lauland1, Hannah Trøstrup3, Tim Tolker-Nielsen2.   

Abstract

Pseudomonas aeruginosa is a key pathogen of chronic infections in the lungs of cystic fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these infections the bacteria congregate in biofilms and cannot be eradicated by standard antibiotic treatment or host immune responses. The persistent biofilms induce a hyper inflammatory state that results in collateral damage of the adjacent host tissue. The host fails to eradicate the biofilm infection, resulting in hindered remodeling and healing. In the present review we describe our current understanding of innate and adaptive immune responses elicited by P. aeruginosa biofilms in cystic fibrosis lung infections and chronic wounds. This includes the mechanisms that are involved in the activation of the immune responses, as well as the effector functions, the antimicrobial components and the associated tissue destruction. The mechanisms by which the biofilms evade immune responses, and potential treatment targets of the immune response are also discussed.
Copyright © 2021 Moser, Jensen, Thomsen, Kolpen, Rybtke, Lauland, Trøstrup and Tolker-Nielsen.

Entities:  

Keywords:  Pseudomonas aeruginosa; adaptive immune response; biofilm infections; innate immune response; novel treatment possibilities

Year:  2021        PMID: 33692800      PMCID: PMC7937708          DOI: 10.3389/fimmu.2021.625597

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  194 in total

1.  Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.

Authors:  Andreas Hector; Heike Schäfer; Simone Pöschel; Alexandra Fischer; Benedikt Fritzsching; Anjali Ralhan; Melanie Carevic; Hasan Öz; Sabine Zundel; Michael Hogardt; Martina Bakele; Nikolaus Rieber; Joachim Riethmueller; Ute Graepler-Mainka; Mirjam Stahl; Annika Bender; Julia-Stefanie Frick; Marcus Mall; Dominik Hartl
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

2.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Sabine Zimmermann; Christof Wagner; Wencke Müller; Gerald Brenner-Weiss; Friederike Hug; Birgit Prior; Ursula Obst; Gertrud Maria Hänsch
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 4.  Cell biology and molecular basis of denitrification.

Authors:  W G Zumft
Journal:  Microbiol Mol Biol Rev       Date:  1997-12       Impact factor: 11.056

5.  Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.

Authors:  C Moser; P O Jensen; O Kobayashi; H P Hougen; Z Song; J Rygaard; A Kharazmi; N H by
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

6.  Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development.

Authors:  G A O'Toole; R Kolter
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

7.  Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation.

Authors:  Kara D Jackson; Melissa Starkey; Stefanie Kremer; Matthew R Parsek; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

8.  Distribution, organization, and ecology of bacteria in chronic wounds.

Authors:  Klaus Kirketerp-Møller; Peter Ø Jensen; Mustafa Fazli; Kit G Madsen; Jette Pedersen; Claus Moser; Tim Tolker-Nielsen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

9.  Oxidative changes of bronchoalveolar proteins in cystic fibrosis.

Authors:  Vitaliy Starosta; Ernst Rietschel; Karl Paul; Ulrich Baumann; Matthias Griese
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes.

Authors:  S Schnyder-Candrian; R M Strieter; S L Kunkel; A Walz
Journal:  J Leukoc Biol       Date:  1995-06       Impact factor: 4.962

View more
  13 in total

1.  Pathogenesis in Pseudomonas aeruginosa PAO1 Biofilm-Associated Is Dependent on the Pyoverdine and Pyocyanin Siderophores by Quorum Sensing Modulation.

Authors:  Sharel Pamela Díaz-Pérez; Christian Said Solis; Jesús Salvador López-Bucio; Juan J Valdez Alarcón; Javier Villegas; Homero Reyes-De la Cruz; Jesús Campos-Garcia
Journal:  Microb Ecol       Date:  2022-08-11       Impact factor: 4.192

Review 2.  The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment.

Authors:  Mads Lichtenberg; Tim Holm Jakobsen; Michael Kühl; Mette Kolpen; Peter Østrup Jensen; Thomas Bjarnsholt
Journal:  FEMS Microbiol Rev       Date:  2022-09-02       Impact factor: 15.177

Review 3.  Burns and biofilms: priority pathogens and in vivo models.

Authors:  Evgenia Maslova; Lara Eisaiankhongi; Folke Sjöberg; Ronan R McCarthy
Journal:  NPJ Biofilms Microbiomes       Date:  2021-09-09       Impact factor: 7.290

Review 4.  Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices.

Authors:  Marina Caldara; Cristina Belgiovine; Eleonora Secchi; Roberto Rusconi
Journal:  Clin Microbiol Rev       Date:  2022-01-19       Impact factor: 50.129

Review 5.  Tolerance and resistance of microbial biofilms.

Authors:  Oana Ciofu; Claus Moser; Peter Østrup Jensen; Niels Høiby
Journal:  Nat Rev Microbiol       Date:  2022-02-03       Impact factor: 78.297

6.  Carbohydrates from Pseudomonas aeruginosa biofilms interact with immune C-type lectins and interfere with their receptor function.

Authors:  Sonali Singh; Yasir Almuhanna; Mohammad Y Alshahrani; Douglas W Lowman; Peter J Rice; Chris Gell; Zuchao Ma; Bridget Graves; Darryl Jackson; Kelly Lee; Rucha Juarez; Janice Koranteng; Sirina Muntaka; Ana C da Silva; Farah Hussain; Gokhan Yilmaz; Francesca Mastrotto; Yasuhiko Irie; Paul Williams; David L Williams; Miguel Cámara; Luisa Martinez-Pomares
Journal:  NPJ Biofilms Microbiomes       Date:  2021-12-08       Impact factor: 7.290

7.  Effects of antibiotic treatment and phagocyte infiltration on development of Pseudomonas aeruginosa biofilm-Insights from the application of a novel PF hydrogel model in vitro and in vivo.

Authors:  Hong Wu; Lulu Song; Joey Kuok Hoong Yam; Marian Plotkin; Hengzhuang Wang; Morten Rybtke; Dror Seliktar; Theodoros Kofidis; Niels Høiby; Tim Tolker-Nielsen; Zhijun Song; Michael Givskov
Journal:  Front Cell Infect Microbiol       Date:  2022-07-26       Impact factor: 6.073

8.  Chlorhexidine Promotes Psl Expression in Pseudomonas aeruginosa That Enhances Cell Aggregation with Preserved Pathogenicity Demonstrates an Adaptation against Antiseptic.

Authors:  Uthaibhorn Singkham-In; Pornpimol Phuengmaung; Jiradej Makjaroen; Wilasinee Saisorn; Thansita Bhunyakarnjanarat; Tanittha Chatsuwan; Chintana Chirathaworn; Wiwat Chancharoenthana; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 9.  Pseudomonas aeruginosa: Recent Advances in Vaccine Development.

Authors:  Matthew Killough; Aoife Maria Rodgers; Rebecca Jo Ingram
Journal:  Vaccines (Basel)       Date:  2022-07-08

Review 10.  SagS and its unorthodox contributions to Pseudomonas aeruginosa biofilm development.

Authors:  Soyoung Park; Karin Sauer
Journal:  Biofilm       Date:  2021-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.